# JENTADUETO XR
> **NDA208026** · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2016-05-27
## Drug
- **FDA Application Number:** NDA208026
- **Application type:** New Drug Application
- **Brand name:** JENTADUETO XR
- **Generic name:** LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Active ingredients:** LINAGLIPTIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BOEHRINGER INGELHEIM
- **Manufacturer:** Boehringer Ingelheim Pharmaceuticals, Inc.
- **First approval:** 2016-05-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208026)
---
*AI Analytics · CC0 1.0*